Abstract

PIEDRA-CARVAJAL, William. Entecavir. Acta méd. costarric [online]. 2008, vol.50, suppl.3, pp.53-54. ISSN 0001-6002.

It is a nucleoside analogue of guanosine with selective activity against hepatitis B. It has come out as a therapeutic option for patients who develop resistance to Lamivudine with a security profile similar to this medicine. There is absence of resistance in case of 1 year treatments with a dosage of 1mg/day.

Keywords : entecavir; treatement; hepatitis b; nucleoside analogue.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )